Regeneron Pharmaceuticals, Inc. (REGN)
760.36
+10.89
(+1.45%)
USD |
NASDAQ |
Mar 26, 13:36
Regeneron Pharmaceuticals Market Cap : 80.39B for March 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 190.32B |
| Eli Lilly & Co. | 807.51B |
| Merck & Co., Inc. | 295.48B |
| Pfizer Inc. | 157.43B |
| Johnson & Johnson | 581.49B |
Market Cap Related Metrics
| PE Ratio | 18.29 |
| PS Ratio | 5.759 |
| PEG Ratio | 2.137 |
| Price to Book Value | 2.572 |
| Price to Free Cash Flow | 21.94 |
| Price | 760.36 |
| Earnings Yield | 5.47% |
| PEGY Ratio | 2.024 |
| Operating PE Ratio | 22.31 |
| Normalized PE Ratio | 18.68 |